http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2605626-C2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4a2a31ecc4b935e39123d43b65347199 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-744 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-747 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-747 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-744 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20 |
filingDate | 2015-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2016-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68c571a5bdc2d5c176391b3a912686c7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5469e3340933f1ec23341eee7b66d0b3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da20565db1279e0d5a2f6908fa106793 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a752e9103b1148ce9613885e6219732b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be4b66feef1b50f1b9e21d41e259e5a2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dee9f3b2faa0a0827741ac74f50dcf13 |
publicationDate | 2016-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2605626-C2 |
titleOfInvention | Method of producing bacterial preparation with probiotic activity |
abstract | FIELD: microbiology. n SUBSTANCE: invention relates to microbiology and can be used for manufacturing of functional food products. Method of producing bacterial preparation with probiotic activity based on species of normal human intestinal microflora, involving extraction of bifidobacteria and lactobacilli from human excrements, their cultivation on liquid nutrient medium in anaerobic conditions at temperature 37 °C with subsequent centrifugation and separation of bacterial preparation. Excrements of adult healthy subject are used, who does not take antibiotic or probiotic preparations for 3 months before extraction, streptococci and enterococci are additionally extracted from excrements. Culturing is carried out on medium containing (g/l): yeast extract - 5.0; papain overcook of soya flour - 10.0; sodium hydrophosphate - 1.0; Tween-80 - 0.2; ammonium citrate - 1.0; cysteine hydrochloride - 0.5; magnesium chloride - 0.5; ascorbic acid - 0.5; glucose - 10.0; meat extract - 20.0; manganese sulphate - 0.05; sodium azide - 0.2. Or cultivation can be performed on medium containing (g/l): proteose peptone - 15.0; papain overcook of soya flour - 10.0; sodium hydrophosphate - 1.5; Tween-80 - 1.0; ammonium citrate - 2.0; cysteine hydrochloride - 1.0; magnesium chloride - 0.5; ascorbic acid - 0.2; sodium chloride - 2.5; glucose - 10.0; meat extract - 10.0; sodium azide - 0.2. Or cultivation can be performed on medium containing (g/l): yeast extract - 10.0; pancreatic hydrolysate of casein - 20.0; sodium hydrophosphate - 2.5; Tween-80 - 0.7; lactose - 5.0; ammonium citrate - 0.5; cysteine hydrochloride - 1.0; magnesium chloride - 1.0; ascorbic acid - 0.1; sodium acetate - 0.2; sodium chloride - 3.0; glucose - 5.0; meat extract - 15.0; manganese sulphate - 0.1; sodium azide - 0.2. Cultivation is performed till concentration of microorganisms reaches 1.0·10 8 COE/ml. n EFFECT: method enables to obtain probiotic preparation with antagonistic properties towards pathogenic and opportunistic pathogens, as well as antioxidant, hepatoprotective and anticancer activity. n 1 cl, 2 tbl, 3 ex |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2773131-C2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2771136-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2743696-C1 |
priorityDate | 2015-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 78.